BRIGHT-4 trial: bivalirudin strikes back – Authors' reply
We thank Pierre-Guillaume Piriou and colleagues for their interest in our Article.1
Stay updated with breaking news from Impulse Dynamics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
We thank Pierre-Guillaume Piriou and colleagues for their interest in our Article.1
Trial Evaluates FDA-Designated Breakthrough Therapy for Patients Who Lack Treatment Options
Impulse Dynamics Announces 100th Implant Milestone in China for CCM® Therapy Experience Continues to Show CCM Therapy Addresses Clinical Need in Treating Heart Failure GlobeNewswire November 16, 2022 MARLTON, N.J., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart...
Experience Continues to Show CCM Therapy Addresses Clinical Need in Treating Heart Failure...
Investegate announcements from Impulse Dynamics, Impulse Dynamics Announces 100th Implant Milestone in China for CCM® Therapy